Evoke Pharma (NASDAQ:EVOK) just reported results for the second quarter of 2024.
- Evoke Pharma reported earnings per share of -93 cents. This was below the analyst estimate for EPS of -6 cents.
- The company reported revenue of $2.55 million.
- This was 14.40% worse than the analyst estimate for revenue of $2.98 million.